Clinical Trial Update: Nesiritide Use Following Cardiac Surgery in Infants [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on using nesiritide after cardiac surgery in infants; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiopulmonary Bypass
• Heart Defects Congenital

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Boston Children's Hospital | Conditions: Heart Defects, Congenital, Cardiopulmonary Bypass | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-08-27